ADMA Biologics’ ADMA shares have lost 8.9% in a month against the industry’s growth of 6.6%. The company has put up a ...

1 WaveLINE-010 is a pivotal, randomized, open-label study which plans to enroll approximately ... antigen-positive are eligible for enrollment if they have received hepatitis B virus (HBV) antiviral ...

Find Hepatitis C Virus stock video, 4K footage, and other HD footage from iStock. Get higher quality Hepatitis C Virus content, for less—All of our 4K video clips are the same price as HD. Video Back ...

We conducted a phase 3, multinational, open-label, randomized ... regimens that included various combinations of bedaquiline (B), delamanid (D), linezolid (L), levofloxacin (Lfx) or moxifloxacin ...

Rituximab, a monoclonal antibody directed against the CD20 molecule found on pre-B cells and mature B cells ... is often associated with hepatitis C virus (HCV) infection, and leads to a ...

Exclusion Criteria: * Use of prohibited medications, as specified in the protocol * History of ongoing, chronic or recurrent infectious disease (i.e., human immunodeficiency virus (HIV), hepatitis B ...

Ocrevus should not be given to people with an active hepatitis B virus (HBV) infection ... of the OPERA studies could enroll in an open-label extension, where all are being treated with Ocrevus ...

Potential serious side effects include severe infusion reactions and infections (e.g., herpes virus, PML, and reactivation of hepatitis B). Summary of Infused DMTs ... Gilenya—fingolimod hcl capsule ...

Researchers at Oregon Health & Science University have developed the first transgenic nonhuman primate model—genetically ...

Existing treatment criteria for chronic hepatitis B virus (HBV) infection are mainly based on data from observational studies, such as the REVEAL study from Taiwan, which was initiated in the early ...

With several drugs in use that inhibit the hepatitis B virus polymerases (nucleos(t)ide analogues (or NUCs)), some argue that new direct-acting antiviral drugs, and new NUCs in particular ...